PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 205 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $540,000 | -24.8% | 64,000 | +245.9% | 0.06% | -37.3% |
| Q1 2019 | $718,000 | -27.4% | 18,500 | +85.0% | 0.10% | -75.4% |
| Q4 2017 | $989,000 | -67.0% | 10,000 | -60.0% | 0.41% | -52.7% |
| Q3 2017 | $2,994,000 | -9.1% | 25,000 | -49.1% | 0.88% | -12.4% |
| Q3 2016 | $3,294,000 | – | 49,125 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 507,500 | $121,074,000 | 24.90% |
| BB BIOTECH AG | 476,991 | $113,796,000 | 4.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $1,356,668,000 | 3.35% |
| WEATHERBIE CAPITAL, LLC | 101,055 | $24,109,000 | 2.26% |
| Avalon Global Asset Management LLC | 16,000 | $3,817,000 | 2.24% |
| Redmile Group, LLC | 51,025 | $12,173,000 | 1.41% |
| Fernwood Investment Management, LLC | 6,700 | $1,598,000 | 1.38% |
| Iguana Healthcare Management, LLC | 10,000 | $2,386,000 | 1.27% |
| LMR Partners LLP | 56,632 | $13,510,000 | 1.08% |
| FRANKLIN STREET ADVISORS INC /NC | 21,990 | $5,246,000 | 1.00% |